版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
1、Department of PharmacologyZhongShan Medical collegeSun Yat-sen UniversityDiureticsMingming Ma馬明明 The concept of diureticsDiuretics are drugs that increase the rate of urine flowClinically useful diuretics also increase the rate of excretion of Na+ (natriuresis) and of an panying anion, usually Cl-An
2、 aquaretic causes an increase excretion of solute-free waterBecause natriuretics almost always increase water excretion, they are usually called diuretics.Formation of urineUltrafiltrate 120ml/min (180L/d)Urine 1 ml/min (1-2L/d) 99% ultrafiltrate is reabsorbednephronBasic unitEfficiency of Na+ excre
3、tion (H, I, L)Mechanism and targetsK+-sparing or notClassification of diureticsCarbonic anhydrase inhibitors (L)Osmotic diureticsLoop diuretics (H)Thiazides / Thiazides-like diuretics (I)Aldosterone antagonists (L)Antidiuretic hormone (ADH) antagonists65% NaSixtypesCarbonic anhydrase inhibitors Carb
4、onic anhydrase inhibitorsCarbonic anhydrase inhibitorsProximal convoluted tubule (PCT)Na+/H+ exchanger (NHE3)Carbonic anhydrase (CA)Na+-K+-ATPaseUrinary excretion of HCO3-, K+ and water Carbonic anhydrase inhibitorsAcetazolamide 乙酰唑胺 a: reduce aqueous humor formation and decrease the intraocular pre
5、ssure Acute mountain sickness: decrease cerebrospinal fluid formation and the pH of the cerebrospinal fluid and brainUrinary alkalinization: prevent uric acid and cystine calculi, but can lead to calcium and phosphoric stone formationMetabolic alkalosis: especially useful in correcting the alkalosis
6、 which is due to excessive use of diuretics in patients with severe heart failure【Therapeutic Uses 】Carbonic anhydrase inhibitorsHyperchloremic metabolic acidosis: chronic reduction of body HCO3- stores by CA inhibitors Renal stones: phosphaturia and hypercalciuriaRenal potassium wasting: the increa
7、sed Na+ presented to the collecting tubule is partially reabsorbed, enhancing K+ secretionOther toxicities: nervous system toxicity (drowsiness, paresthesias), hypersensitivity reactions (fever, rashes, bone marrow suppression, and interstitial nephritis)【Toxicity 】LowOsmoticHighOsmoticOsmotic diure
8、ticsCarbonic anhydrase inhibitors【Clinical uses】Increase urine volume: increase water excretion in preference to sodium excretionReduction of intracranial and intraocular pressure【Toxicity】Extracellular volume expansion: due to increase in extracellular osmotic pressure Dehydration, hyperkalemia, an
9、d hypernatremia: excessive use of manitol without water replacementHyponatremia: in patients with severe renal impairmentOsmotic diuretics Mannitol 甘露醇, sorbitol 山梨醇, glucose 葡萄糖 (iv. not po.)25% NaSixtypesLoop diureticsCarbonic anhydrase inhibitorsLoop diureticsThick ascending limb (TAL)Na+/K+/2Cl-
10、 cotransporter (NKCC2, NK2Cl)Na+-K+-ATPaseUrinary excretion of Na+ , K+ , Cl-, water, Mg2+ 【Pharmacokinetics】 The loop diuretics are rapidly absorbed and eliminated by the kidney by glomerular filtration and tubular secretion.Plasma protein binding rate is 95%, their diuretic activity correlates wit
11、h their secretion by the proximal tubule.Reduction in the secretion of loop diuretics may result from simultaneous administration of agents such as NSAIDs or probenecid, which compete for weak acid secretion in the proximal tubule.Loop diureticsthe high efficacious diuretic agents【Clinical Uses】Edem
12、atous condition: heart failure, chronic renal failure, hepatic cirrhosisHypercalcemia: reduce Ca2+ reabsorptionHyperkalemia: enhance urinary excretion of K+Acute renal failure: increase the rate of urine flow and enhance K+ excretion in acute renal failureAnion overdose: useful in treating toxic ing
13、estions of bromide, fluoride, and iodide Loop diureticsFurosemide 呋塞米 /Bumetanide 布美他尼/ Ethacrynic acid 依他尼酸【Toxicity】 Hypokalemic metabolic alkalosis: increase Na+ delivery to the collecting duct, which leads to increased secretion of K+ and H+ by the ductHypomagnesemia: rarely cause hypocalcemiaHy
14、peruricemia: precipitate attacks of goutOtotoxicity: dose-related hearing loss (aminoglycoside)Allergic & other reactions: skin rash, eosinophilia, interstitial nephritisLoop diureticsSixtypes10% NaThiazides diureticsCarbonic anhydrase inhibitorsThiazides diureticsDistal convoluted tubule (DCT)Na+ a
15、nd Cl- cotransporter (NCC)Na+-K+-ATPaseParathyroid hormone (PTH)Na+/Ca2+ exchangerCA inhibitorUrinary excretion of Na+ , Cl, water, K+ , Mg2+, HCO3- Ca2+【Pharmacokinetics】 Like carbonic anhydrase inhibitors and loop diuretic, all of the thiazides have an unsubstituted sulfonamideChlorothiazide is th
16、e only thiazide available for parenteral administrationHydrochlorothiazide is considerably more potent and should be used in much lower dosesAll thiazides are secreted by the organic acid secretory system in the proximal tubule and compete with the secretion of uric acid by that system. As a result,
17、 thiazide use may blunt uric acid secretion and elevate serum uric acid level.Thiazidesthe intermediate efficacious diuretic agents【Clinical Uses】Hypertension: hydrochlorothiazide is the most widely used diuretic for hypertension (first line) Heart failure: reduce salt and water retentionNephrolithi
18、asis: due to idiopathic hypercalciuriaNephrogenic diabetes insipidus: Diatary sodium restriction can potentiate the benefical effects ThiazidesHydrochlorothiazide (HCTZ) 氫氯噻嗪/ Chlorothiazide 氯噻嗪【Toxicity】 Hypokalemic metabolic alkalosis and hyperuricemia : similar to loop diureticsHyponatremia: caus
19、ed by a combination of hypovolemia-induced elevation of antidiuretic hormone (ADH)Impaired carbohydrate tolerance: impaired pancreatic release of insulin and diminished tissue utilization of glucose Hyperlipidemia : 515% increase in total serum cholesterol and low-density lipoproteins (LDLs)Allergic
20、 reactions : photosensitive or generalized dermatitisThiazides2-5% NaSixtypesK+-SparingdiureticsCarbonic anhydrase inhibitorsK+-sparing diureticsCollecting tubulePrincipal cellIntercalated cellEpithelial Na+ channel (ENaC)AldosteroneNa+-K+-ATPaseUrinary excretion of Na+, water K+, H+ Mineralocortico
21、id receptor aldosterone-induced proteinsIncrease the new synthesis of Na+ channel and K+ channel as well as fibrotic and inflammatory proteins【Pharmacokinetics】 Spironolactone is a synthetic steroid that may cause endocrine abnormalities by actions on other steroid receptors, which has a rather slow
22、 onset of action, requiring several days before full therapeutic effect is achieved.Eplerenone is a spironalactone analog with much greater selectivity for the mineralocorticoid receptor, therefore, eplerenone has considerably fewer adverse effects.Amiloride and triamterene are direct inhibitors of
23、Na+ infux in the CT.K+-sparing diureticsthe low efficacious diuretic agents【Clinical Uses】Hyperaldosteronism: primary (Conns syndrome) or secondary (evoked by heart failure, hepatic cirrhosis, nephrotic syndrome)Hypertension: combination with other diuretics (prevent K+ loss) Eplerenone: low dose of
24、 eplerenone may interfere with some of the fibrotic and inflammatory effects of aldosterone K+-sparing diureticsSpironolactone 螺內(nèi)酯/ eplerenone 依普利酮/ amiloride 阿米洛利/ triamterene 氨苯蝶啶【Toxicity】 Hyperkelemia: due to reduced urinary excretion of K+Hyperchloremic metabolic acidosis: due to reduced H+ secretion in parallel with K+ secretion astia : synthetic steroids may cause endocrine abnormalities by actions on other steroid receptors (spironolactone)Acute renal failure: caused by the combination of triamterene with indomethacinKidney stones : triamterene is only sli
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 高三物理總復習-直線運動-勻變速直線運動的規(guī)律課件
- 現(xiàn)代氣動與液壓技術(shù) 課件 6鉆床進給系統(tǒng)調(diào)壓回路的仿真與裝調(diào)
- 北師大小學數(shù)學三年級上冊課件:第2節(jié)第2課時除加、除減混合運算的應用
- 高三化學知識點復習課件17
- 人教版五下數(shù)學第1課時-旋轉(zhuǎn)公開課教案課件
- 人教小學數(shù)學三年級下冊:第2單元除數(shù)是一位數(shù)的除法第7課時商末尾有0的除法課件
- 江蘇省鹽城市鹽都區(qū)多校聯(lián)考2024-2025學年七年級9月月考道德與法治試題(解析版)
- 云南省昆明市(2024年-2025年小學四年級語文)人教版能力評測(上學期)試卷及答案
- 湖北省荊門市(2024年-2025年小學四年級語文)人教版專題練習(上學期)試卷及答案
- 課程敘事講座課件:課程敘事課程自覺專業(yè)成長
- 電子政務概論-形考任務5(在線測試權(quán)重20%)-國開-參考資料
- 2024專精特新上市公司創(chuàng)新與發(fā)展報告
- 北京市定向選調(diào)真題
- 中國企業(yè)投資緬甸光伏發(fā)電市場機會分析及戰(zhàn)略規(guī)劃報告2024-2030年
- 2024-2030年中國凍干食品行業(yè)市場發(fā)展趨勢與前景展望戰(zhàn)略分析報告
- 智聯(lián)國企行測筆試真題
- 2024-2030年中國家用(別墅)電梯行業(yè)發(fā)展趨勢及市場前景預測分析研究報告
- 課《聞王昌齡左遷龍標遙有此寄》跨學科公開課一等獎創(chuàng)新教學設(shè)計
- 為商品和服務的買賣雙方提供在線市場行業(yè)發(fā)展全景調(diào)研與投資趨勢預測研究報告
- 2024年無人機巡檢工安全操作技能及理論知識考試題庫(附含答案)
- 外出參加學術(shù)會議審批表
評論
0/150
提交評論